Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: An immunohistochemical study-Reference-Cited by-同舟云学术

Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: An immunohistochemical study

Published:2011-12 Issue:2 Volume:232 Page:149-153
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Shibuya Kazumoto,Misawa Sonoko,Arai Kimihito,Nakata Miho,Kanai Kazuaki,Yoshiyama Yasumasa,Ito Kimiko,Isose Sagiri,Noto Yu-ichi,Nasu Saiko,Sekiguchi Yukari,Fujimaki Yumi,Ohmori Shigeki,Kitamura Hiroshi,Sato Yasunori,Kuwabara Satoshi

Funder

Ministry of Health, Labour and Welfare

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference33 articles.

1. ALS drug development: reflections from the past and a way forward;Aggarwal;Neurotherapeutics,2008

2. Axonal ion channel dysfunction in amyotrophic lateral sclerosis;Bostock;Brain,1995

3. Natural history of ALS: symptoms, strength, pulmonary function, and disability;Brooks;Neurology,1996

4. Amyotrophic lateral sclerosis: hypothetical pathogenesis;Brown;Med. Hypotheses,1994

5. Amyotrophic lateral sclerosis. Its natural history;Caroscio;Neurol. Clin.,1987

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulation of cortical hyperexcitability in amyotrophic lateral sclerosis: focusing on glial mechanisms;Molecular Neurodegeneration;2023-10-19

2. Astrocytic K⁺ clearance during disease progression in amyotrophic lateral sclerosis;Glia;2023-07-03

3. The Node of Ranvier as an Interface for Axo-Glial Interactions: Perturbation of Axo-Glial Interactions in Various Neurological Disorders;Journal of Neuroimmune Pharmacology;2023-06

4. Motoneuron excitability dysfunction in ALS: Pseudo‐mystery or authentic conundrum?;The Journal of Physiology;2022-10-19

5. Ion Channels and Neurodegenerative Disease Aging Related;Ion Transporters - From Basic Properties to Medical Treatment;2022-10-05